Nasdaq also created the Nasdaq Biotechnology Index (NBI) on November 1, 1993, which is comprised of dynamic and innovative biotech companies listed on the exchange. The NBI is currently up 4.9% ...

NASDAQ National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. Since cheaper funds tend to produce better results than more expensive funds, assuming ...

tracks S&P Biotechnology Select Industry Index and the iShares Biotechnology ETF (IBB) tracks Nasdaq Biotechnology Index. SPDR S&P Biotech ETF has $5.79 billion in assets, iShares Biotechnology ...

tracks S&P Biotechnology Select Industry Index and the iShares Biotechnology ETF (IBB) tracks Nasdaq Biotechnology Index. SPDR S&P Biotech ETF has $6.13 billion in assets, iShares Biotechnology ...

The Nasdaq Biotechnology Index has increased 2.62% in the past five trading sessions and MRNA’s shares increased 4.85%. In the past six months, shares of MRNA have plunged 52.06%. (See the last ...

The total return index values for the NASDAQ Composite Index, NASDAQ-100 Index, and NASDAQ Biotechnology Index were synchronized to the value of original corresponding indexes at the close on ...

Shares of clinical-stage biotech Chimerix skyrocketed following an acquisition agreement from Jazz Pharmaceuticals for $8.55 per share in cash, aggregating to nearly $935 million. The offer price ...

Fisher Asset Management LLC raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 19.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 2,544 shares of the ...

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the ...